Journal profile · Medicine-Oncology
Klinicheskaya Onkogematologiya/Clinical Oncohematology
ISSN 1997-6933 · eISSN 2500-2139 · Practical Medicine Publishing House · Russian Federation
Klinicheskaya Onkogematologiya/Clinical Oncohematology: diamond open access (no APC); no APC; review about 12 weeks (community reports); 51 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Klinicheskaya Onkogematologiya/Clinical Oncohematology is published by Practical Medicine Publishing House. By OpenAlex counts of its recent articles, its largest topics are Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research and Acute Myeloid Leukemia Research, together about 36.9% of its articles. Its main subfields are Hematology. (generated from OpenAlex topic counts and CAS ranking data)
Clinical Oncohematology is an open access, peer-reviewed online journal. It encompasses all aspects of hematology and oncology in all basic and clinical fields with special focus on lymphoid malignancies, myeloid malignancies, bone marrow transplantation, complications of anti-tumor treatment and supportive care. The journal publishes original research, reviews, clinical reports, commentaries, clinical and laboratory observations and guidelines. Clinical Oncohematology aims to serve as a platform for sharing laboratory and clinical findings in an open access format among laboratory scientists, physician scientists, hematologists and oncologists with most rapid turnaround time possible from submission to publication.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Oncology
Editor-in-chief Gayane Sepugovna TumyanPublisher website
Editorial board by country: none in mainland China; most named Russia 17, United States 2, Germany 1, Switzerland 1 (21 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Lymphoma Diagnosis and TreatmentMedicine16.5%
- Chronic Lymphocytic Leukemia ResearchMedicine11.5%
- Acute Myeloid Leukemia ResearchMedicine8.8%
- Hematopoietic Stem Cell TransplantationMedicine8.4%
- Viral-associated cancers and disordersMedicine7.4%
- Hematological disorders and diagnosticsMedicine6%
- Multiple Myeloma Research and TreatmentsMedicine5.9%
- Acute Lymphoblastic Leukemia researchMedicine4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Hematology | Q4 | 127/151 | 16th |
| Oncology | Q4 | 363/428 | 15th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
SCIEWeb of ScienceMEDLINEPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.7LetPub ·
- SJR 2026-06
- 0.11LetPub ·
- SNIP 2026-06
- 0.16LetPub ·
- h-index
- 11OpenAlex ·
- i10-index
- 14OpenAlex ·
- 2-year mean citedness
- 0.34OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 723 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 51 | 51 | 141 |
| 2025 | 51 | 51 | 142 |
| 2024 | 47 | 47 | 140 |
| 2023 | 49 | 49 | 163 |
| 2022 | 41 | 41 | 137 |
| 2021 | 59 | 59 | 135 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 12 weeksLetPub ·
- Submission to publication (journal-reported)
- about 10 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC-SA | |
| LetPub | No APC | No | — | |
| Publisher website | No APC | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Abstract
- 200–250 words
- Reference style
- Vancouver
- Not considered
- copyright transfer agreement
Article types accepted11
- clinical and laboratory studiesResearch-based papers can be published under the following categories: clinical studies and case reports; hematopoiesis and stem cells; immunobiology and immuno…Length not stated
- clinical studies and case reportsResearch-based papers can be published under the following categories: clinical studies and case reports; hematopoiesis and stem cells; immunobiology and immuno…Length not stated
- experimental biology and experimental therapyResearch-based papers can be published under the following categories: clinical studies and case reports; hematopoiesis and stem cells; immunobiology and immuno…Length not stated
- gene and cell therapyResearch-based papers can be published under the following categories: clinical studies and case reports; hematopoiesis and stem cells; immunobiology and immuno…Length not stated
- hematopoiesis and stem cellsResearch-based papers can be published under the following categories: clinical studies and case reports; hematopoiesis and stem cells; immunobiology and immuno…Length not stated
- hematopoietic stem cell transplantationResearch-based papers can be published under the following categories: clinical studies and case reports; hematopoiesis and stem cells; immunobiology and immuno…Length not stated
- immunobiology and immunotherapyResearch-based papers can be published under the following categories: clinical studies and case reports; hematopoiesis and stem cells; immunobiology and immuno…Length not stated
- intensive and supportive therapies in oncohematologyResearch-based papers can be published under the following categories: clinical studies and case reports; hematopoiesis and stem cells; immunobiology and immuno…Length not stated
- myeloid and lymphoid neoplasmsResearch-based papers can be published under the following categories: clinical studies and case reports; hematopoiesis and stem cells; immunobiology and immuno…Length not stated
- original researchClinical Oncohematology accepts manuscripts not published earlier in Russian and English academic literature. Articles must be written exclusively in Russian. T…Length not stated
- reviewClinical Oncohematology accepts manuscripts not published earlier in Russian and English academic literature. Articles must be written exclusively in Russian. T…Length not stated
Policy excerpts from the journal's websitePublication ethics, License & copyright, Open access, Peer review
- Publication ethics
Publishing Ethics and Malpractice Statement Model summary
Publishing Ethics and Malpractice Statement
Source ↗Publisher website ·- License & copyright Copyright transfer
Copyright transfer agreement required. Model summary
Upon acceptance of an article, authors will be asked to complete a 'Copyright Transfer Agreement'. Download a sample of Copyright Transfer Agreement form here. How to prepare your manuscript Font: Times New Roman, 12 point, left aligned, 1,5-spaced. Title: use 18 point bold for your article title; font size 16 and 14 pt for first- and second-level headings respectively. File structure: The journal…
Source ↗Publisher website ·- Open access
No publication fees (APC-free). Model summary
The publication of articles in the Journal is free of charge.
Source ↗Publisher website ·- Peer review
Peer review process. Model summary
All articles manuscripts are subjected to the peer-review.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Practical Medicine Publishing House
- Country or region
- Russian Federation
- Language
- Russian
- ISSN
- 1997-6933
- Electronic ISSN
- 2500-2139
- Latest issue on the website
- Volume 19, Issue 3 (2026)
- Official links
FAQ
Frequently asked questions about Klinicheskaya Onkogematologiya/Clinical Oncohematology
How long does peer review take at Klinicheskaya Onkogematologiya/Clinical Oncohematology?
Authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Klinicheskaya Onkogematologiya/Clinical Oncohematology?
According to the journal's author guidelines: Abstract: 200–250 words; Reference style: Vancouver. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Klinicheskaya Onkogematologiya/Clinical Oncohematology based?
Of the 21 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Russia (17), United States (2) and Germany (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Klinicheskaya Onkogematologiya/Clinical Oncohematology?
According to LetPub and DOAJ records, Klinicheskaya Onkogematologiya/Clinical Oncohematology is indexed in Scopus and DOAJ. The journal's website also lists SCIE, Web of Science and MEDLINE; that list has not been checked against each database.
Is Klinicheskaya Onkogematologiya/Clinical Oncohematology open access, and what is the APC?
Klinicheskaya Onkogematologiya/Clinical Oncohematology is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .